These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 15934028

  • 1. Meta-analysis of the efficacy of the acetonic kava-kava extract WS1490 in patients with non-psychotic anxiety disorders.
    Witte S, Loew D, Gaus W.
    Phytother Res; 2005 Mar; 19(3):183-8. PubMed ID: 15934028
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines.
    Malsch U, Kieser M.
    Psychopharmacology (Berl); 2001 Sep; 157(3):277-83. PubMed ID: 11605083
    [Abstract] [Full Text] [Related]

  • 3. Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trial.
    Volz HP, Kieser M.
    Pharmacopsychiatry; 1997 Jan; 30(1):1-5. PubMed ID: 9065962
    [Abstract] [Full Text] [Related]

  • 4. Kava treatment in patients with anxiety.
    Geier FP, Konstantinowicz T.
    Phytother Res; 2004 Apr; 18(4):297-300. PubMed ID: 15162364
    [Abstract] [Full Text] [Related]

  • 5. Treatment of anxiety, tension and restlessness states with Kava special extract WS 1490 in general practice: a randomized placebo-controlled double-blind multicenter trial.
    Gastpar M, Klimm HD.
    Phytomedicine; 2003 Nov; 10(8):631-9. PubMed ID: 14692723
    [Abstract] [Full Text] [Related]

  • 6. Kava Anxiety Depression Spectrum Study (KADSS): a mixed methods RCT using an aqueous extract of Piper methysticum.
    Sarris J, Kavanagh DJ, Adams J, Bone K, Byrne G.
    Complement Ther Med; 2009 Jun; 17(3):176-8. PubMed ID: 19398072
    [Abstract] [Full Text] [Related]

  • 7. [Effect of a special kava extract in patients with anxiety-, tension-, and excitation states of non-psychotic genesis. Double blind study with placebos over 4 weeks].
    Kinzler E, Krömer J, Lehmann E.
    Arzneimittelforschung; 1991 Jun; 41(6):584-8. PubMed ID: 1930344
    [Abstract] [Full Text] [Related]

  • 8. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
    Sarris J, Teschke R, Stough C, Scholey A, Schweitzer I.
    Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850
    [Abstract] [Full Text] [Related]

  • 9. Kava-kava extract in anxiety disorders: an outpatient observational study.
    Scherer J.
    Adv Ther; 1998 Jan; 15(4):261-9. PubMed ID: 10186945
    [Abstract] [Full Text] [Related]

  • 10. Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study.
    Sarris J, Stough C, Bousman CA, Wahid ZT, Murray G, Teschke R, Savage KM, Dowell A, Ng C, Schweitzer I.
    J Clin Psychopharmacol; 2013 Oct; 33(5):643-8. PubMed ID: 23635869
    [Abstract] [Full Text] [Related]

  • 11. Kava: a comprehensive review of efficacy, safety, and psychopharmacology.
    Sarris J, LaPorte E, Schweitzer I.
    Aust N Z J Psychiatry; 2011 Jan; 45(1):27-35. PubMed ID: 21073405
    [Abstract] [Full Text] [Related]

  • 12. Kava.
    Harv Womens Health Watch; 1998 Aug; 5(12):6. PubMed ID: 9713242
    [No Abstract] [Full Text] [Related]

  • 13. Is kava extract effective for treating anxiety?
    Abadi S, Papoushek C, Evans MF.
    Can Fam Physician; 2001 Sep; 47():1745-7. PubMed ID: 11570299
    [No Abstract] [Full Text] [Related]

  • 14. Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial.
    Savage KM, Stough CK, Byrne GJ, Scholey A, Bousman C, Murphy J, Macdonald P, Suo C, Hughes M, Thomas S, Teschke R, Xing C, Sarris J.
    Trials; 2015 Nov 02; 16():493. PubMed ID: 26527536
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of kava extract for treating anxiety: systematic review and meta-analysis.
    Pittler MH, Ernst E.
    J Clin Psychopharmacol; 2000 Feb 02; 20(1):84-9. PubMed ID: 10653213
    [Abstract] [Full Text] [Related]

  • 16. [Assessment of the association of Kava-Kava extract and hormone replacement therapy in the treatment of postmenopause anxiety].
    De Leo V, La Marca A, Lanzetta D, Palazzi S, Torricelli M, Facchini C, Morgante G.
    Minerva Ginecol; 2000 Jun 02; 52(6):263-7. PubMed ID: 11085051
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of diazepam as an anti-anxiety agent: meta-analysis of double-blind, randomized controlled trials carried out in Japan.
    Inada T, Nozaki S, Inagaki A, Furukawa TA.
    Hum Psychopharmacol; 2003 Aug 02; 18(6):483-7. PubMed ID: 12923829
    [Abstract] [Full Text] [Related]

  • 18. Herbal and dietary supplements for treatment of anxiety disorders.
    Saeed SA, Bloch RM, Antonacci DJ.
    Am Fam Physician; 2007 Aug 15; 76(4):549-56. PubMed ID: 17853630
    [Abstract] [Full Text] [Related]

  • 19. Complementary and alternative medicine in the treatment of anxiety and depression.
    van der Watt G, Laugharne J, Janca A.
    Curr Opin Psychiatry; 2008 Jan 15; 21(1):37-42. PubMed ID: 18281839
    [Abstract] [Full Text] [Related]

  • 20. Kava-Kava extract LI 150 is as effective as Opipramol and Buspirone in Generalised Anxiety Disorder--an 8-week randomized, double-blind multi-centre clinical trial in 129 out-patients.
    Boerner RJ, Sommer H, Berger W, Kuhn U, Schmidt U, Mannel M.
    Phytomedicine; 2003 Jan 15; 10 Suppl 4():38-49. PubMed ID: 12807341
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.